Searched for
PAXLOVID
Over 20% Covid-infected people taking Paxlovid experience viral rebound: StudyA study by researchers at Mass General Brigham hospital in Boston found that one in five COVID-infected individuals treated with antiviral ...- Hetero gets WHO prequalification for generic Covid antiviral PaxlovidThis is the first WHO prequalification for Paxlovid - a combination of nirmatrelvir and ritonavir which is recommended for treating mild an...
- Pfizer CEO Albert Bourla tests positive for Covid, says has very mild symptomsPfizer Inc Chief Executive Officer Albert Bourla said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid,...
- Why do some people who take Paxlovid for Covid get 'rebound' symptoms or test positive again?In a clinical trial, Paxlovid showed an 89% reduction in the risk of hospitalisation and death.
- Joe Biden again tests positive for COVID-19, says he feels fineBiden's positive test is believed to be a "rebound" experienced by some COVID patients who take the anti-viral drug Paxlovid, according to ...
- Zenara Pharma gets CDSCO nod to launch Covid antiviral Paxlovid in IndiaThe approval by the Central Drugs Standard Control Organization (CDSCO) has been granted under the emergency authorization route considerin...
- Drugmakers seem to be in no hurry to launch Covid antiviral pill PaxlovidSeveral industry executives and doctors ET spoke to said at the moment, while cases are rising, the need for Paxlovid hasn't been felt as c...
- Rare cases of COVID returning pose questions for Pfizer pillPaxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disea...
- ICMR task force meets to discuss inclusion of Pfizer’s Paxlovid for Covid treatmentPfizer’s Paxlovid contains Nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and Ritonavir, which slows...
- Optimus too could launch Covid pill Paxlovid soonThe company has conducted bioavailability and bioequivalence (BA/BE) studies and is likely to submit the safety data to the drug regulator ...
- Pfizer's "game-changing" COVID-19 pill, Paxlovid, gets DCGI nodPfizer had last year announced a deal with MPP, a UN-backed body, to issue royalty-free voluntary licences to manufacture generic versions ...
- World Health Organization 'strongly recommends' Pfizer's COVID-19 pillUS pharma giant Pfizer's combination of nirmatrelvir and ritonavir was the "superior choice" of treatment for unvaccinated, elderly or immu...
- Cipla to conduct study on PaxlovidIn its meeting held this week, the SEC granted approval to the company to conduct bioavailability and bio equivalence (BA/BE) studies. “Cip...
- Nod for Paxlovid's Indian generic version to take longerHetero Labs and Optimus Pharma had approached the drug regulatory authority last month seeking waivers from conducting local trials. Howeve...
- China approves use of Pfizer's COVID drug PaxlovidThe National Medical Products Administration said Paxlovid is approved to treat adults who have mild to moderate COVID-19 and high risk of ...
- Pfizer plans tiered pricing for its Covid antiviral PaxlovidPfizer has signed a voluntary licensing with UN-backed Medicines Patent Pool (MPP) allowing the latter to grant sub-licences of Paxlovid to...
- Pfizer may offer Covid antiviral drug to India at lower price for nowPfizer has entered into advance purchase agreements with multiple countries. Sources told ET that Pfizer is yet to apply for emergency use ...
- Pill 88% effective if given early, says PfizerFinal results of Paxlovid demonstrated reduction of hospitalisation or death by 89% among high-risk patients treated within three days of s...
- Pfizer says antiviral pill cut hospitalisation by 89%, neutralised Omicron in lab testsThe company said the 88% efficacy in patients treated within five days of symptom onset, was an increase from the 85% observed in the inter...
- Pfizer's pill is the latest COVID treatment to show promise. Here are some moreAccording to Pfizer's trial results, Paxlovid could be used as an alternative to in-hospital treatment for preventing disease progression i...
Load More
